Anaesthetic care for sickle cell disease

Area of Science:

• Anesthesiology
• Hematology
• Internal Medicine

Background:

• Sickle cell disease (SCD) is prevalent in Europe but often poorly managed.
• Anesthesiologists play a critical role during hospital stays, a key period for SCD management.
• Understanding hemoglobin S polymerization is crucial for preventing sickle cell crises.

Purpose of the Study:

• To highlight the importance of anesthesiologist involvement in managing sickle cell disease.
• To discuss strategies for optimizing perioperative risk assessment and management in SCD patients.
• To emphasize the need for improved understanding of SCD pathophysiology for better clinical care.

Main Methods:

• Review of current literature on sickle cell disease management and anesthesia.
• Analysis of factors influencing perioperative risk in SCD patients.
• Discussion of anesthetic techniques and preoperative/postoperative care protocols.

Main Results:

• Hemoglobin S polymerization and phenotype differentiation are key to assessing perioperative risk.
• Organ damage (liver, spleen, eyes, bones, lungs, CNS) significantly increases perioperative risk.
• General anesthesia may be preferable for high-risk SCD patients over regional anesthesia.
• Preoperative preparation involves early admission, fluid management, pain control, and antibiotics.
• Careful monitoring to avoid hypoxemia, hypovolemia, hypothermia, acidosis, and overtransfusion is essential.

Conclusions:

• Optimizing perioperative care for sickle cell disease patients requires a comprehensive approach.
• Anesthesiologists must be knowledgeable about SCD pathophysiology and risk factors.
• Effective pain management, combining opioids and non-opioid analgesics, is vital for postoperative recovery.